Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.69
0.71%
After-hours: Aug 15, 2025, 06:19 PM EDT
Cadrenal Therapeutics Common Stock Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | n/a | -2.11 | -1.32 | -1.56 | -0.78 | -1.49 | -2.11 | -2.14 | -4.41 | -0.8 | -2.39 | -171.62 | -357.98 | -1.01K |
PEG Ratio | n/a | 0.09 | -0.05 | 0.58 | -0.02 | -0.09 | -0.19 | 0.30 | 0.05 | -0.32 | -0.00 | -1.58 | -1.96 | n/a |
PS Ratio | n/a | n/a | 10.35K | n/a | n/a | n/a | 3.48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.50 | 5.32 | 2.97 | 4.42 | 1.86 | 1.61 | 1.25 | 1.01 | 5.57 | 4.07 | -8.64 | -609.43 | -1.07K | n/a |
P/FCF Ratio | -7.82 | -6.99 | -12.3 | -6.85 | -4.86 | -5.41 | -13.81 | -14.11 | -22.26 | -11.7 | -166.47 | 710.49K | n/a | -16.45K |
P/OCF Ratio | -7.81 | -6.99 | -12.34 | -6.85 | -4.86 | -5.41 | -13.88 | -14.11 | -22.26 | -11.7 | -165.17 | 710.49K | n/a | -16.45K |
OCF/S Ratio | n/a | n/a | -839.13 | n/a | n/a | n/a | -250.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | -0.12 | -0.45 | -0.63 | n/a |
Quick Ratio | 3.56 | 4.32 | 3.77 | 3.69 | 3.60 | 8.01 | 10.27 | 16.46 | 9.40 | 11.05 | 0.55 | 0.81 | 0.71 | n/a |
Current Ratio | 3.56 | 4.32 | 3.77 | 3.69 | 3.60 | 8.01 | 10.27 | 16.46 | 9.40 | 11.05 | 0.55 | 0.81 | 0.71 | n/a |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -245.61 | -19.31 | -30.39 | -32.66 | -37.49 |
Return on Equity | n/a | -0.63 | -0.56 | -0.71 | -0.6 | -0.27 | -0.15 | -0.12 | -0.32 | -1.27 | 0.90 | 0.89 | 0.75 | n/a |
Return on Assets | n/a | -0.48 | -0.41 | -0.51 | -0.44 | -0.24 | -0.13 | -0.11 | -0.28 | -1.15 | -6.44 | -1.92 | -2.06 | n/a |
Return on Invested Capital | -0.87 | -0.64 | -0.58 | -0.72 | -0.62 | -0.28 | -0.16 | -0.13 | -0.32 | -1.02 | 2.18 | 7.82 | 5.01 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.78 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -1.96K | n/a | n/a | n/a | -413.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -1.96K | n/a | n/a | n/a | -413.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -2K | n/a | n/a | n/a | -456.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -1.96K | n/a | n/a | n/a | -413.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |